Free Trial
NYSE:CTVA

Corteva Q1 2026 Earnings Report

Corteva logo
$83.91 +2.22 (+2.72%)
Closing price 05/5/2026 03:59 PM Eastern
Extended Trading
$83.70 -0.21 (-0.25%)
As of 05/5/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Upcoming Event
Earnings Conference Call
Corteva Q1 2026
00:00 / 00:00
Live Transcript
Follow Audio

Corteva EPS Results

Actual EPS
$1.50
Consensus EPS
$1.18
Beat/Miss
Beat by +$0.32
One Year Ago EPS
$1.13

Corteva Revenue Results

Actual Revenue
$4.91 billion
Expected Revenue
$4.64 billion
Beat/Miss
Beat by +$266.00 million
YoY Revenue Growth
+11.00%

Corteva Announcement Details

Quarter
Q1 2026
Time
After Market Closes
Conference Call Date
Wednesday, May 6, 2026
Conference Call Time
9:00AM ET

Earnings Documents

Corteva Earnings Headlines

Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel
See More Corteva Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Corteva? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Corteva and other key companies, straight to your email.

About Corteva

Corteva (NYSE:CTVA) (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals. The company markets improved seed varieties for major row crops, invests in breeding and biotechnology to enhance yield and resilience, and offers precision‑agriculture and digital platforms designed to optimize input use and agronomic decisions. Corteva also works with channel partners to supply seed, crop protection products and advisory services to growers.

Corteva is headquartered in the United States and operates on a global scale, serving farmers and distributors across the Americas, Europe, Asia and other agricultural regions. The company emphasizes ongoing R&D investment, product stewardship and collaboration with growers, industry partners and academic institutions to advance sustainable productivity. Information on specific executive leadership is not provided here to avoid inaccuracy; investors should consult company filings or the corporate website for up‑to‑date leadership details.

View Corteva Profile